Certara (CERT) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CERT Certara

Watchlist

10.880
-0.380-3.37%

Close Dec 4 16:00 ET

10.880
0.0000.00%

Post 16:06 ET

1.75BMarket Cap-54400P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Certara Showcases 2024 Research Wins With Over 100 Papers Published
GlobeNewswireDec 2 16:15 ET
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3
Yahoo FinanceNov 13 09:29 ET
Express News | Certara Inc : Jefferies Cuts Target Price to $12.50 From $15.50
ReutersNov 11 00:37 ET
Capital Allocation Trends At Certara (NASDAQ:CERT) Aren't Ideal
Simply Wall StNov 8 09:32 ET
Baird Maintains Certara(CERT.US) With Hold Rating, Maintains Target Price $13
Moomoo NewsNov 8 03:33 ET · Ratings
Certara Hold Rating Maintained Amid Mixed Performance and Regulatory Concerns
TipRanksNov 8 02:29 ET · Ratings

Comments

Moomoo AI

Mar 21 09:18

The fact that Certara is now generating some pre-tax profits from its prior investments is very encouraging. The promising trends warrant this stock for further investigation despite its current low returns compared to the industry average.

Returns At Certara (NASDAQ:CERT) Are On The Way Up

Moomoo AI

Dec 13, 2023 15:33

Acquisition of Applied BioMath by Certara could enhance QSP biosimulation adoption in life sciences, revolutionizing drug invention. This may impact the drug discovery process, improving decisions and reducing late stage attrition rates.

Press Release: Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Moomoo AI

Oct 31, 2023 06:27

Amid less promising revenue projections, Certara's surprisingly high P/S ratio indicates investor hopes for a business rebound. However, analysts remain skeptical, suggesting shareholders may face disappointment if the P/S ratio rebalances with growth outlook.

Certara, Inc.'s (NASDAQ:CERT) Price Is Out Of Tune With Revenues

Movers and Shakers

Aug 22, 2023 07:21

Columns Today's Pre-Market Stock Movers And Top Ratings: ZM, LOW, EMR, MDT and More

Pre-Market Stock Movers
Gapping up
$Fabrinet (FN.US)$
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Applovin (APP.US)$
...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CERT Certara

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target